NOVABAY PHARMACEUTICALS INC (NBY)       0.1181  +0.01 (+7.36%)

0.1181  +0.01 (+7.36%)

US66987P2011 - Common Stock - Premarket: 0.1179 0 (-0.17%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q2 2022 -0.04 -0.04 0.00-13.15% Q1 2022 -0.05 -0.03 -0.02-65.02% Q4 2021 -0.02 -0.05 0.0360.40% Q3 2021 -0.05 -0.04 -0.01-23.76% Q2 2021 -0.04 -0.04 0.000.99% Q1 2021 -0.04 -0.04 0.000.99% Q4 2020 -0.04 -0.05 0.0111.99% Q3 2020 -0.08 -0.04 -0.04-98.02%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -0.09 -0.15 42.77%Q3 2022 -0.03 -0.05 49.50%Q4 2022 -0.01 -0.02 49.50%FY 2023 -0.04 -0.09 52.94%Q1 2023 -0.03 -0.05 49.50%Q2 2023 -0.02 -0.04 49.50%Q3 2023 -0.01 -0.03 80.00%Q4 2023 0.01 -0.01 150.00%FY 2024 0.00 -0.04 100.00%Q1 2024 -0.02 -0.03 20.00%Q2 2024 0.00 -0.02 100.00%Q3 2024 0.01 -0.01 300.00%Q4 2024 0.01 0.01 100.00%FY 2025 0.00 0.00 %FY 2026 0.00 0.00 %

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q2 2022 3.045M 3.545M -500.1K-14.11% Q1 2022 2.629M 3.293M -663.6K-20.15% Q4 2021 2.641M 3.378M -737.45K-21.83% Q3 2021 1.84M 2.459M -619.35K-25.18% Q2 2021 2.133M 2.02M 113K5.59% Q1 2021 1.807M 2.363M -556.4K-23.54% Q4 2020 1.888M 2.505M -616.8K-24.62% Q3 2020 2.17M 2.55M -380.25K-14.91%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 16.104M 8.421M 91.24%Q3 2022 4.798M 1.84M 160.73%Q4 2022 6.232M 2.641M 135.96%FY 2023 25.533M 16.104M 58.54%Q1 2023 4.979M 2.629M 89.40%Q2 2023 5.54M 3.045M 81.93%Q3 2023 7.055M 4.798M 47.05%Q4 2023 7.959M 6.232M 27.71%FY 2024 35.249M 25.533M 38.05%Q1 2024 7.11M 4.979M 42.80%Q2 2024 8.444M 5.54M 52.42%Q3 2024 9.504M 7.055M 34.72%Q4 2024 10.181M 7.959M 27.92%FY 2025 51.756M 35.249M 46.83%FY 2026 76.755M 51.756M 48.30%